Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation

    NEXT STORY
    Oncology Venture reaches new development milestone with Dovitinib.
    PREV STORY
    Oncology Venture is streamlining its communications by publishing press releases in English only going forward.
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Innate Pharma and MedImmune enter clinical trial collaboration

    Innate Pharma and MEDIMMUnE Enter clinical trial collaboration Innate Pharma and MedImmune will evaluate ...

    author_avatar
    NASDAQ Market News

    Global Point-of-Care Diagnostics, Health & Biosensors Conference 2019: POC Testing Landscape, Novel Technologies to Regulatory Approval (San Diego, CA, United States – October 7-9, 2019)

    author_avatar
    NASDAQ Market News

    Strongbridge Biopharma plc Announces RECORLEV™ (levoketoconazole) Phase 3 SONICS Data Published in The Lancet Diabetes & Endocrinology

    author_avatar
    NASDAQ Market News